Back to results
US 2026/0265253 A1Published application
Novel methods
AssigneeIntra-Cellular Therapies, Inc.
InventorsSharon MATES, Robert DAVIS, Kimberly VANOVER
Life of this patent
Estimating the term…
Abstract
Use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals for the treatment of agitation, aggressive behaviors, posttraumatic stress disorder or impulse control disorders.
Claims26
A method for the treatment of a disorder selected from agitation or aggressive behavior, comprising administering to a patient in need thereof an effective amount of a compound of Formula I:
- wherein X is O, —NH or —N(CH3);
- and Y is —O—, —C(H)(OH)— or —C(O)—, in free or pharmaceutically acceptable salt form.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.